BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 8274273)

  • 1. Molecular localization of regions in the L-type calcium channel critical for dihydropyridine action.
    Tang S; Yatani A; Bahinski A; Mori Y; Schwartz A
    Neuron; 1993 Dec; 11(6):1013-21. PubMed ID: 8274273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motif III S5 of L-type calcium channels is involved in the dihydropyridine binding site. A combined radioligand binding and electrophysiological study.
    He M; Bodi I; Mikala G; Schwartz A
    J Biol Chem; 1997 Jan; 272(5):2629-33. PubMed ID: 9006896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels.
    Grabner M; Wang Z; Hering S; Striessnig J; Glossmann H
    Neuron; 1996 Jan; 16(1):207-18. PubMed ID: 8562085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular studies on the voltage dependence of dihydropyridine action on L-type Ca2+ channels. Critical involvement of tyrosine residues in motif IIIS6 and IVS6.
    Bodi I; Yamaguchi H; Hara M; He M; Schwartz A; Varadi G
    J Biol Chem; 1997 Oct; 272(40):24952-60. PubMed ID: 9312099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain.
    Huber I; Wappl E; Herzog A; Mitterdorfer J; Glossmann H; Langer T; Striessnig J
    Biochem J; 2000 May; 347 Pt 3(Pt 3):829-36. PubMed ID: 10769189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordination of Ca2+ by the pore region glutamates is essential for high-affinity dihydropyridine binding to the cardiac Ca2+ channel alpha 1 subunit.
    Mitterdorfer J; Sinnegger MJ; Grabner M; Striessnig J; Glossmann H
    Biochemistry; 1995 Jul; 34(29):9350-5. PubMed ID: 7626604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a high-affinity receptor site for dihydropyridine agonists and antagonists by single amino acid substitutions in a non-L-type Ca2+ channel.
    Hockerman GH; Peterson BZ; Sharp E; Tanada TN; Scheuer T; Catterall WA
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14906-11. PubMed ID: 9405712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of channel characteristics by exchange of pore-forming regions between two structurally related Ca2+ channels.
    Yatani A; Bahinski A; Wakamori M; Tang S; Mori Y; Kobayashi T; Schwartz A
    Mol Cell Biochem; 1994 Nov; 140(2):93-102. PubMed ID: 7898492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinctions in the molecular determinants of charged and neutral dihydropyridine block of L-type calcium channels.
    Lacinová L; An RH; Xia J; Ito H; Klugbauer N; Triggle D; Hofmann F; Kass RS
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1472-9. PubMed ID: 10336541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular determinants of high affinity dihydropyridine binding in L-type calcium channels.
    Peterson BZ; Tanada TN; Catterall WA
    J Biol Chem; 1996 Mar; 271(10):5293-6. PubMed ID: 8621376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of dihydropyridine interaction with critical binding residues of L-type Ca2+ channel alpha 1 subunits.
    Wappl E; Mitterdorfer J; Glossmann H; Striessnig J
    J Biol Chem; 2001 Apr; 276(16):12730-5. PubMed ID: 11278630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two amino acid residues in the IIIS5 segment of L-type calcium channels differentially contribute to 1,4-dihydropyridine sensitivity.
    Mitterdorfer J; Wang Z; Sinnegger MJ; Hering S; Striessnig J; Grabner M; Glossmann H
    J Biol Chem; 1996 Nov; 271(48):30330-5. PubMed ID: 8939992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfer of the high affinity dihydropyridine sensitivity from L-type To non-L-type calcium channel.
    Ito H; Klugbauer N; Hofmann F
    Mol Pharmacol; 1997 Oct; 52(4):735-40. PubMed ID: 9380037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key roles of Phe1112 and Ser1115 in the pore-forming IIIS5-S6 linker of L-type Ca2+ channel alpha1C subunit (CaV 1.2) in binding of dihydropyridines and action of Ca2+ channel agonists.
    Yamaguchi S; Zhorov BS; Yoshioka K; Nagao T; Ichijo H; Adachi-Akahane S
    Mol Pharmacol; 2003 Aug; 64(2):235-48. PubMed ID: 12869628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nine L-type amino acid residues confer full 1,4-dihydropyridine sensitivity to the neuronal calcium channel alpha1A subunit. Role of L-type Met1188.
    Sinnegger MJ; Wang Z; Grabner M; Hering S; Striessnig J; Glossmann H; Mitterdorfer J
    J Biol Chem; 1997 Oct; 272(44):27686-93. PubMed ID: 9346909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serine residue in the IIIS5-S6 linker of the L-type Ca2+ channel alpha 1C subunit is the critical determinant of the action of dihydropyridine Ca2+ channel agonists.
    Yamaguchi S; Okamura Y; Nagao T; Adachi-Akahane S
    J Biol Chem; 2000 Dec; 275(52):41504-11. PubMed ID: 11022040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary structure and functional expression of the cardiac dihydropyridine-sensitive calcium channel.
    Mikami A; Imoto K; Tanabe T; Niidome T; Mori Y; Takeshima H; Narumiya S; Numa S
    Nature; 1989 Jul; 340(6230):230-3. PubMed ID: 2474130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium binding in the pore of L-type calcium channels modulates high affinity dihydropyridine binding.
    Peterson BZ; Catterall WA
    J Biol Chem; 1995 Aug; 270(31):18201-4. PubMed ID: 7629136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-type calcium channels: asymmetrical intramembrane binding domain revealed by variable length, permanently charged 1,4-dihydropyridines.
    Bangalore R; Baindur N; Rutledge A; Triggle DJ; Kass RS
    Mol Pharmacol; 1994 Oct; 46(4):660-6. PubMed ID: 7969044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoform-specific inhibition of L-type calcium channels by dihydropyridines is independent of isoform-specific gating properties.
    Hu H; Marban E
    Mol Pharmacol; 1998 May; 53(5):902-7. PubMed ID: 9584217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.